Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion

• Published in: Scientific reports Vol. 11; no. 1; pp. 8303 - 7
• Main Authors: Wecker, Thomas, Grundel, Bastian, Grundel, Milena, Bründer, Marie-Christine, Trick, Simon, Lange, Clemens, Böhringer, Daniel, Agostini, Hansjürgen, Stahl, Andreas
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 15.04.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308; 692/699/3161/3175; Acuity; Cataracts; Corticoids; Corticosteroids; Dexamethasone; Edema; Electronic medical records; Eye; Humanities and Social Sciences; multidisciplinary; Occlusion; Patients; Retina; Science; Science (multidisciplinary); Steroids; Surgery; Transplants & implants; Vascular endothelial growth factor

Macular edema (ME) is the most frequent vision threatening consequence after retinal vein occlusion (RVO). In this study, we evaluate the effect of dexamethasone intravitreal implants (DII, Ozurdex) in a real-life cohort of 99 patients with ME due to RVO. All patients who received DII for ME followi...